arrow
L

Luís Felipe Ensina

Federal University of Sao Paulo
H指数:29
被引数:6,697

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
2025-11-150
OAAI
Real-World Evidence on the Management of Hereditary Angioedema with Normal C1 Inhibitor

关于C1抑制因子正常的遗传性血管性水肿的管理真实世界证据

2025-10-100
PRE
Internationale Umfrage zur Behandlungspraktiken bei atopischer Dermatitis bei schwangeren und stillenden Frauen: Perspektiven von Ärzten

妊娠及哺乳期特应性皮炎治疗实践国际调查:医生视角

2025-09-150
OAAI
The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D Study

症状性划痕症患病率:国际UCARE PREVALENCE-D研究的结果

2025-09-130
OAAI
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement

儿童药物超敏反应的临床实践:WAO声明

2025-08-290
OAAI
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement

更新NSAID高敏感性反应的分类和常规诊断:一份WAO声明

2025-08-120
OAAI
Mucosal angioedema involving the oropharynx signals severe cold urticaria: COLD-CE study insights

涉及口咽部的黏膜血管性水肿预示严重寒冷性荨麻疹:COLD-CE研究见解

2025-07-230
PRE
Urticaria and other mimickers of urticaria
2025-02-130
OAAI
Age- and Elicitor-Dependent Characterization of Hymenoptera Venom-Induced Anaphylaxis in Children and Adolescents
2025-01-010
OAAI
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study
2024-10-240
PRE
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice

特应性皮炎和慢性荨麻疹患者报告的结局指标在临床实践中使用不足

2024-06-013
OAAI
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
LANCET
IF88.5
2024-01-0113
PRE